BioStem Tech (BSEM)
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenera...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
BioStem Tech Analyst Rating
View moreForecast & Rating
Aug 24, 2026Price forecast
$7.0069.08%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Sep 21 at 08:31 PM
BioStem Technologies joins Terminal1 investor relations platform
- businessinsider · Sep 19 at 03:49 AM
BioStem Technologies files to sell 12.05M shares of common stock for holders
- TradingView · Sep 18 at 08:33 PM
BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal Investments
- benzinga_article · Sep 18 at 05:05 PM
12 Health Care Stocks Moving In Friday's Intraday Session
- PUBT · Sep 18 at 11:00 AM
BioStem secures USD 40 million equity facility via private placement with Roth affiliate
